| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $56K | -60.6% |
| R&D Expense | $7.5M | +919.1% |
| SG&A Expense | $9.6M | +3.2% |
| Operating Income | -$17.0M | -72.4% |
| Pre-tax Income | -$11.1M | -175.3% |
| Income Tax | $0 | — |
| Net Income | -$11.1M | +24.7% |
| EPS (Basic) | -$1.51 | +89.0% |
| EPS (Diluted) | -$1.51 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.7M | +964.3% |
| Current Assets | $5.7M | +652.8% |
| Total Assets | $6.7M | -43.8% |
| Current Liabilities | $2.4M | -60.0% |
| Total Liabilities | $6.2M | -5.9% |
| Stockholders' Equity | $641K | -88.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.1M | -119.7% |
| Investing Cash Flow | -$22K | +99.8% |
| Financing Cash Flow | $13.2M | -24.5% |
| +89.0% |